A randomized controlled trial of Naoxintong Capsule to reduce major cardiovascular adverse events (MACE) in patients with acute coronary syndrome (ACS)

Category Primary study
Registry of TrialsInternational Traditional Medicine Clinical Trial Registry
Year 2020
This article has no abstract
Epistemonikos ID: 76cc3b8d7d983ff790b736c87bfea6c7a2262c1a
First added on: Apr 11, 2025